Challenges Facing Adverse Drug Reactions Reporting and Counterfeit Drugs Monitoring

View Sample PDF

Copyright: 2018
Pages: 20
Source title: Advanced Systems for Improved Public Healthcare and Disease Prevention: Emerging Research and Opportunities
Source Author(s)/Editor(s): Thierry Oscar Edoh (Technical University of Munich, Germany)
DOI: 10.4018/978-1-5225-5528-5.ch004

Keywords: Health Information Systems / Medical Information Science Reference / Medicine & Healthcare / Public Health & Healthcare Delivery

Purchase

View Challenges Facing Adverse Drug Reactions Reporting and Counterfeit Drugs Monitoring on the publisher's website for pricing and purchasing information.

Abstract

This chapter investigates in a case study the limitations of adverse drug reactions reporting (ADRr) and the challenges facing counterfeit drugs monitoring in the African developing countries with a focus on the Republic of Benin and proposes solutions to improve the adverse drug reporting method and infrastructures as well as the counterfeit drugs monitoring. The study aims at implementing an ADRr system using the m-health technology to overcome the limitations and ease the use of the “yellow card” in the developing world. Furthermore, a real-time notification system is provided to promptly disseminate among the populations any registered and proved ADR.

The IRMA Community

Research IRM

Challenges Facing Adverse Drug Reactions Reporting and Counterfeit Drugs Monitoring

Purchase

Abstract

Related Content

IRMA Sponsors